Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials

Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials

Abstract Currently, pyridostigmine bromide is an indispensable anticholinesterase agent used worldwide to treat patients with Myasthenia Gravis (MG). However, pyridostigmine bromide was unsuccessful in its “pioneering trials” to treat a series of MG patients. There are important historical landmarks...

Full description

Saved in:
Bibliographic Details
Main Authors: LORENZONI,Paulo José, KAY,Cláudia Suemi Kamoi, DUCCI,Renata Dal-Prá, FUSTES,Otto Jesus Hernandez, WERNECK,Lineu Cesar, SCOLA,Rosana Herminia
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000300179
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items